Gene therapy progress and prospects cancer: oncolytic viruses.
about
Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancerGoing viral: a review of replication-selective oncolytic adenovirusesAnti-tumor activity of a miR-199-dependent oncolytic adenovirusAn Ecological Framework of the Human Virome Provides Classification of Current Knowledge and Identifies Areas of Forthcoming DiscoveryGene Therapy: A Paradigm Shift in DentistryNovel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomasEngineering of Brome mosaic virus for biomedical applicationsTherapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimeticDevelopment of a selective biopharmaceutical from Herpes simplex virus type 1 glycoproteins E and I for blocking antibody mediated neutralization of oncolytic viruses.Gene Therapy and its Implications in Dentistry.Targeting a mimotope vaccine to activating Fcgamma receptors empowers dendritic cells to prime specific CD8+ T cell responses in tumor-bearing mice.Enhanced antitumor effects of an engineered measles virus Edmonston strain expressing the wild-type N, P, L genes on human renal cell carcinomaAntiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice.Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment.Indole-3-carbinol (I3C) increases apoptosis, represses growth of cancer cells, and enhances adenovirus-mediated oncolysisDevelopment of a regulatable oncolytic herpes simplex virus type 1 recombinant virus for tumor therapy.Complete regression of human malignant mesothelioma xenografts following local injection of midkine promoter-driven oncolytic adenovirusA single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models.Targeting cancer-initiating cells with oncolytic viruses.Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma.Oncolytic measles virus encoding thyroidal sodium iodide symporter for squamous cell cancer of the head and neck radiovirotherapy.Polyethyleneimine-modified calcium carbonate nanoparticles for p53 gene deliveryExperimental Adaptation of Rotaviruses to Tumor Cell Lines.Effective oncolytic vaccinia therapy for human sarcomas.Systemic delivery of oncolytic adenoviruses targeting transforming growth factor-β inhibits established bone metastasis in a prostate cancer mouse model.Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.Characterization of an Oncolytic Adenovirus Vector Constructed to Target the cMet ReceptorA novel armed oncolytic measles vaccine virus for the treatment of cholangiocarcinomaEmerging cancer vaccines: the promise of genetic vectors.Immunotherapy for liver tumors: present status and future prospects.Oncolytic adenovirus mediated Survivin knockdown by RNA interference suppresses human colorectal carcinoma growth in vitro and in vivoCoronavirus genetically redirected to the epidermal growth factor receptor exhibits effective antitumor activity against a malignant glioblastomaOncolytic vaccinia therapy of squamous cell carcinoma.Gene therapy in Alzheimer's disease - potential for disease modificationA novel oncolytic viral therapy and imaging technique for gastric cancer using a genetically engineered vaccinia virus carrying the human sodium iodide symporter.In vitro dynamic visualization analysis of fluorescently labeled minor capsid protein IX and core protein V by simultaneous detectionHypoxia-regulated overexpression of soluble VEGFR2 controls angiogenesis and inhibits tumor growth.Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways.Possible applications for replicating HIV 1 vectorsUpdate on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool.
P2860
Q24611278-D215D714-DE52-4BB7-A7ED-E91E8379FA2DQ26797520-523F8CA2-D738-41BB-A85A-CD86CC4FB050Q27307206-0D189DC7-9DDA-477D-95E0-29B68494883EQ27468626-F4B68FD3-82B4-44D5-AA54-B590A89A837CQ28076033-9A9A7292-F521-4B71-B573-EB500F5B76CFQ28298788-143A2FA4-B8AA-44BB-A1D3-D8283BB5D469Q28818683-36919069-F975-479E-95F4-873ED293B1F7Q30300019-8B79DDE1-DE22-465B-8B65-49140394766EQ30318510-BC654B9F-EDF5-48E4-B6F6-12CC42775894Q30356405-D2405759-7E82-44A8-9464-FB7A20CE49ABQ33584637-F0509C9A-D33A-4D55-B87B-0A9A836DA181Q33731148-D0C4B84D-38BB-47C6-82E9-F85C59A244E7Q33815701-DC526EB5-1F6B-43D3-B1E6-C1B217E3B24FQ33824400-D05F24FF-70EB-4DAC-9DFD-54D6EFF011ECQ34028482-35A5DBEE-EED7-43DE-B116-222034639887Q34046125-B05FDFC6-9251-4FBE-AC31-14B23266051DQ34124614-8559B985-D263-41BD-A90D-723FC271D848Q34480521-2CD17C69-9343-499F-96F9-F927301E6A5DQ34659011-60998097-39EF-4B93-B191-F335C7EF75F4Q35175013-BB135313-B388-4132-8967-621F54E2DB2BQ35823934-70830796-2A7A-481A-9F23-D3D6AF675A4FQ35905841-9F336730-756B-49DB-BB44-ADCF71EC766DQ35909654-21977B60-8599-4518-B5A3-92FD424DCA57Q35954052-31E4AB7B-0FF9-45CA-8F48-A6062D739F96Q36147503-C9976614-8320-4170-AACC-A69F9E3612B9Q36546044-38F60904-B024-4071-8476-0365589AB126Q36558142-87A30B0C-2CBB-410B-86DB-9A4B709915D5Q36848730-34652AE3-030C-4FD0-A3C9-644DA09D3575Q37137464-3E0FD465-2AB9-4993-AEB2-0B673D9EC564Q37144014-F1073849-7CC4-47FC-A674-4FFE7B9FEAE9Q37244951-4288E348-80CC-42CA-AF4A-8AEF67D20C1CQ37256658-CABF4FFE-17AD-4D04-B7C7-DC3A305227AEQ37270539-F7E20967-F269-4A27-9C32-DC1093C4CEEEQ37295252-D97BC14C-CC65-40E8-A221-9A8D128FCBB2Q37444250-9EA586C6-C006-422D-A003-F2EBB259E145Q37456186-6E6FB204-A085-4BE0-987A-F7386AD2FA8DQ37483716-D83E494F-D47C-4532-84D2-9ABD42E3CEDDQ37564490-6555015A-D1E9-4FFB-A630-4A1218E1C84DQ37768033-D4E805CD-CD4B-434F-9AB4-76A1F7C4C382Q37780547-FA451439-2C37-4689-9D81-994A24AAAD58
P2860
Gene therapy progress and prospects cancer: oncolytic viruses.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Gene therapy progress and prospects cancer: oncolytic viruses.
@ast
Gene therapy progress and prospects cancer: oncolytic viruses.
@en
Gene therapy progress and prospects cancer: oncolytic viruses.
@nl
type
label
Gene therapy progress and prospects cancer: oncolytic viruses.
@ast
Gene therapy progress and prospects cancer: oncolytic viruses.
@en
Gene therapy progress and prospects cancer: oncolytic viruses.
@nl
prefLabel
Gene therapy progress and prospects cancer: oncolytic viruses.
@ast
Gene therapy progress and prospects cancer: oncolytic viruses.
@en
Gene therapy progress and prospects cancer: oncolytic viruses.
@nl
P2860
P356
P1433
P1476
Gene therapy progress and prospects cancer: oncolytic viruses
@en
P2093
P2860
P2888
P304
P356
10.1038/GT.2008.72
P577
2008-04-17T00:00:00Z